全文获取类型
收费全文 | 36059篇 |
免费 | 3255篇 |
国内免费 | 164篇 |
专业分类
耳鼻咽喉 | 495篇 |
儿科学 | 1093篇 |
妇产科学 | 654篇 |
基础医学 | 4466篇 |
口腔科学 | 899篇 |
临床医学 | 3710篇 |
内科学 | 7202篇 |
皮肤病学 | 431篇 |
神经病学 | 3484篇 |
特种医学 | 1580篇 |
外科学 | 6056篇 |
综合类 | 653篇 |
一般理论 | 20篇 |
预防医学 | 3378篇 |
眼科学 | 1085篇 |
药学 | 2289篇 |
1篇 | |
中国医学 | 47篇 |
肿瘤学 | 1935篇 |
出版年
2021年 | 383篇 |
2020年 | 306篇 |
2019年 | 385篇 |
2018年 | 484篇 |
2017年 | 434篇 |
2016年 | 508篇 |
2015年 | 761篇 |
2014年 | 1261篇 |
2013年 | 1877篇 |
2012年 | 1846篇 |
2011年 | 2020篇 |
2010年 | 1420篇 |
2009年 | 1394篇 |
2008年 | 1912篇 |
2007年 | 2099篇 |
2006年 | 2141篇 |
2005年 | 2140篇 |
2004年 | 1994篇 |
2003年 | 1992篇 |
2002年 | 2046篇 |
2001年 | 430篇 |
2000年 | 330篇 |
1999年 | 467篇 |
1998年 | 558篇 |
1997年 | 470篇 |
1996年 | 417篇 |
1995年 | 447篇 |
1994年 | 401篇 |
1993年 | 386篇 |
1992年 | 326篇 |
1991年 | 301篇 |
1990年 | 281篇 |
1989年 | 288篇 |
1988年 | 278篇 |
1987年 | 282篇 |
1986年 | 282篇 |
1985年 | 285篇 |
1984年 | 372篇 |
1983年 | 373篇 |
1982年 | 501篇 |
1981年 | 472篇 |
1980年 | 460篇 |
1979年 | 270篇 |
1978年 | 270篇 |
1977年 | 289篇 |
1976年 | 217篇 |
1975年 | 216篇 |
1974年 | 238篇 |
1973年 | 236篇 |
1972年 | 191篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
2.
Ki-Yong An Andria R. Morielli Dong-Woo Kang Christine M. Friedenreich Donald C. McKenzie Karen Gelmon John R. Mackey Robert D. Reid Kerry S. Courneya 《International journal of cancer. Journal international du cancer》2020,146(1):150-160
The Combined Aerobic and Resistance Exercise (CARE) Trial compared different types and doses of exercise performed during breast cancer chemotherapy. Here, we report the longer-term follow-up of patient-reported outcomes, health-related fitness and exercise behavior at 6, 12 and 24 months postintervention. A multicenter trial in Canada randomized 301 breast cancer patients initiating chemotherapy to thrice weekly, supervised exercise consisting of a standard dose of 25–30 min of aerobic exercise (STAN; n = 96), a higher dose of 50–60 min of aerobic exercise (HIGH; n = 101) or a combined dose of 50–60 min of aerobic and resistance exercise (COMB; n = 104) performed for the duration of chemotherapy (median of 17 weeks). Primary outcomes were patient-reported outcomes including quality of life, cancer-related symptoms and psychosocial outcomes. Secondary outcomes were objective health-related fitness (assessed at 12 months only) and self-reported exercise behavior. A total of 269 (89.4%) participants completed patient-reported outcomes at all three follow-up time points and 263 (87.4%) completed the health-related fitness assessment at 12-month follow-up. COMB was significantly superior to (i) STAN for sleep quality at 6-month follow-up (p = 0.027); (ii) HIGH for upper body muscular endurance at 12-month follow-up (p = 0.020); and (iii) HIGH for meeting the resistance exercise guideline at 6-month follow-up (p = 0.006). Moreover, self-reported meeting of the combined exercise guideline during follow-up was significantly associated with better patient-reported outcomes and health-related fitness. Performing combined exercise during and after breast cancer chemotherapy may result in better longer-term patient-reported outcomes and health-related fitness compared to performing aerobic exercise alone. 相似文献
3.
4.
Optimizing glycemic control remains a shared challenge for clinicians and their patients with diabetes. Flash continuous glucose monitoring (CGM) provides immediate information about an individual’s current and projected glucose level, allowing users to respond promptly to mitigate or prevent pending hypoglycemia or hyperglycemia. Large randomized controlled trials (RCTs) have demonstrated the glycemic benefits of flash CGM use in both type 1 and type 2 diabetes. However, whereas RCTs are mostly focused on the efficacy of this technology in defined circumstances, real-world studies can assess its effectiveness in wider clinical settings. This review assesses the most recent real-world studies demonstrating the effectiveness of flash CGM use to improve clinical outcomes and health care resource utilization in populations with diabetes.During the past 5 years, increasing numbers of people with type 1 or type 2 diabetes have integrated continuous glucose monitoring (CGM) into their diabetes self-management regimens. Unlike traditional blood glucose meters, CGM systems provide immediate information about the concentration and the direction and rate of change of interstitial glucose. This information enables patients to intervene promptly to prevent or reduce acute hypoglycemia or hyperglycemia.Flash CGM is among the most recent CGM technologies. Currently, the FreeStyle Libre 14-day system (Abbott Diabetes Care) and FreeStyle Libre 2 are the only flash CGM systems available, and these systems are being adopted rapidly. Large randomized controlled trials (RCTs) have confirmed the glycemic benefits of flash CGM use in people with type 1 diabetes (1,2) and those with type 2 diabetes (3–6). However, because RCTs are mostly focused on measures of efficacy in defined circumstances, real-world studies can usefully assess the effectiveness of flash CGM in wider clinical settings.Although adoption of flash CGM continues to expand within endocrinology and diabetes specialty practices, primary care providers may be less familiar with this technology and how it can benefit patients with diabetes. This review assesses recent real-world studies demonstrating the impact of flash CGM use on clinical outcomes and health care resource utilization in both type 1 and type 2 diabetes populations. 相似文献
5.
6.
7.
Mae Lynn Reyes-Rodríguez Hunna J. Watson Concepción Barrio Donald H. Baucom Yormeri Silva Kiara L. Luna-Reyes 《Eating disorders》2019,27(2):205-229
ABSTRACTLatinos are less likely to seek health care for eating disorders and more likely to drop out of treatment than members of other ethnic groups, highlighting existing challenges to engagement in traditional mental health care. This study explored the role of family in the treatment of adult Latinas with eating disorders through content analysis of family sessions adjunctive to cognitive behavioral therapy. This study yielded insight into the experiences of 10 Latinas with eating disorders (M age = 39.90 years) and 10 relatives (M age = 39.50) from the Promoviendo una Alimentación Saludable trial who were randomly selected to receive six family enhancement sessions. Data from 53 sessions were analyzed using a qualitative content analysis approach. Family intervention might serve as a valuable adjunct to conventional treatment by positively influencing social, family, and emotional support for Latinas with eating disorders. 相似文献
8.
9.